In summary, understanding the regulatory mechanisms of ferroptosis and its interactions with the immune microenvironment offers valuable insights and promising therapeutic targets for developing novel treatments for SA-AKI, including Nrf2 pathway agonists, immune cell modulators, and iron chelators. This evidence concerns the gene NFE2L2 and acute kidney injury.